Cargando…

T7 expression plasmids for producing a recombinant human G1P[8] rotavirus comprising RIX4414 sequences of the RV1 (Rotarix , GSK) vaccine strain

The live oral rotavirus RV1 (Rotarix) vaccine is formulated from the human G1P[8] RIX4414 virus. Based on RIX4414 sequences, T7 expression plasmids were constructed that supported recovery of recombinant RIX4414-like viruses by reverse genetics. These plasmids will advance the study of the RV1 vacci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Philip, Asha A., Agbemabiese, Chantal A., Yi, Guanghui, Patton, John T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2023
Materias:	Other Genetic Resources
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652971/ https://www.ncbi.nlm.nih.gov/pubmed/37819123 http://dx.doi.org/10.1128/MRA.00603-23

Ejemplares similares

Pharmacoeconomic Spotlight on Rotavirus Vaccine RIX4414 (Rotarix™) in Developed Countries
por: Plosker, Greg L.
Publicado: (2012)

Post-marketing safety surveillance conducted in Korea (2008–2013) following the introduction of the rotavirus vaccine, RIX4414 (Rotarix™)
por: Shin, Son Moon, et al.
Publicado: (2016)

Will vaccination against rotavirus infection with RIX4414 be cost-saving in Germany?
por: Knoll, Stefanie, et al.
Publicado: (2013)

Early exposure of infants to natural rotavirus infection: a review of studies with human rotavirus vaccine RIX4414
por: Cunliffe, Nigel, et al.
Publicado: (2014)

Human rotavirus vaccine (RIX4414) efficacy in the first two years of life: A randomized, placebo-controlled trial in China
por: Li, Rong-cheng, et al.
Publicado: (2014)

Immunogenicity and reactogenicity of the human rotavirus vaccine, RIX4414 oral suspension, when co-administered with routine childhood vaccines in Chinese infants
por: Li, Rong-cheng, et al.
Publicado: (2015)

Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis
por: Rose, Johnie, et al.
Publicado: (2009)

Reactogenicity and safety of a liquid human rotavirus vaccine (RIX4414) in healthy adults, children and infants in China: Randomized, double-blind, placebo-controlled Phase I studies
por: Li, Rong-Cheng, et al.
Publicado: (2013)

The human rotavirus vaccine Rotarix™ in infants: An integrated analysis of safety and reactogenicity
por: Buyse, Hubert, et al.
Publicado: (2014)

Immunogenicity of rotavirus vaccine (Rotarix(TM)) in infants with environmental enteric dysfunction
por: Mwape, Innocent, et al.
Publicado: (2017)

Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of ROTARIX and ROTAVAC
por: Debellut, Frédéric, et al.
Publicado: (2020)

Quanty4RIXS: a program for crystal field multiplet calculations of RIXS and RIXS–MCD spectra using Quanty
por: Zimmermann, Patric, et al.
Publicado: (2018)

Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial
por: Steele, Andrew Duncan, et al.
Publicado: (2012)

Comparative analysis of the Rotarix™ vaccine strain and G1P[8] rotaviruses detected before and after vaccine introduction in Belgium
por: Zeller, Mark, et al.
Publicado: (2017)

Effect of innate antiviral glycoproteins in breast milk on seroconversion to rotavirus vaccine (Rotarix) in children in Lusaka, Zambia
por: Mwila-Kazimbaya, Katayi, et al.
Publicado: (2017)

The evolving epidemiology of rotavirus A infection in Brazil a decade after the introduction of universal vaccination with Rotarix®
por: Carvalho-Costa, Filipe A., et al.
Publicado: (2019)

Serologic response to porcine circovirus type 1 (PCV1) in infants vaccinated with the human rotavirus vaccine, Rotarix™: A retrospective laboratory analysis
por: Han, Htay Htay, et al.
Publicado: (2016)

Rotarix in Japan: Expectations and Concerns
por: Nakagomi, Osamu, et al.
Publicado: (2011)

Comparative Analysis of G1P[8] Rotaviruses Identified Prior to Vaccine Implementation in Pakistan With Rotarix™ and RotaTeq™ Vaccine Strains
por: Sadiq, Asma, et al.
Publicado: (2020)

Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on Intussusception
por: Singh, Tina, et al.
Publicado: (2022)

Rotavirus NSP1 Subverts the Antiviral Oligoadenylate Synthetase-RNase L Pathway by Inducing RNase L Degradation
por: Dai, Jin, et al.
Publicado: (2022)

Mr. William Howells Rix
Publicado: (1910)

Corrigendum: Comparative Analysis of G1P[8] Rotaviruses Identified Prior to Vaccine Implementation in Pakistan With Rotarix™ and RotaTeq™ Vaccine Strains
por: Sadiq, Asma, et al.
Publicado: (2020)

Unorthodox branching ratios of the psi'''(4.414) as radial excitation of charmonium
por: Caichian, M, et al.
Publicado: (1978)

Reactogenicity and safety of the human rotavirus vaccine, Rotarix™ in The Philippines, Sri Lanka, and India: A post-marketing surveillance study
por: Bravo, Lulu, et al.
Publicado: (2014)

Correction to: Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on Intussusception
por: Singh, Tina, et al.
Publicado: (2022)

Epidemiological trends for hospital admissions for acute rotavirus gastroenteritis in Belgium following the introduction of routine rotavirus vaccination and the subsequent switch from lyophilized to liquid formulation of Rotarix(™)
por: RAES, M., et al.
Publicado: (2016)

GSK3β Inhibition Promotes Efficient Myeloid and Lymphoid Hematopoiesis from Non-human Primate-Induced Pluripotent Stem Cells
por: D'Souza, Saritha S., et al.
Publicado: (2016)

Human neonatal rotavirus vaccine (RV3-BB) targets rotavirus from birth
por: Bines, Julie E., et al.
Publicado: (2018)

A Cost Effectiveness and Capacity Analysis for the Introduction of Universal Rotavirus Vaccination in Kenya: Comparison between Rotarix and RotaTeq Vaccines
por: van Hoek, Albert Jan, et al.
Publicado: (2012)

4414 Collagen Dermal Replacement Scaffold Mechanobiology in Treatment of Difficult-to-Heal Wounds
por: Sohutskay, David Oleh, et al.
Publicado: (2020)

Correction: A Cost Effectiveness and Capacity Analysis for the Introduction of Universal Rotavirus Vaccination in Kenya: Comparison between Rotarix and RotaTeq Vaccines
por: van Hoek, Albert Jan, et al.
Publicado: (2012)

The pGinger Family of Expression Plasmids
por: Pearson, Allison N., et al.
Publicado: (2023)

Comparative whole genome analysis reveals re-emergence of human Wa-like and DS-1-like G3 rotaviruses after Rotarix vaccine introduction in Malawi
por: Mhango, Chimwemwe, et al.
Publicado: (2023)

LAS1L interacts with the mammalian Rix1 complex to regulate ribosome biogenesis
por: Castle, Christopher D., et al.
Publicado: (2012)

Next-generation plasmids for transgenesis in zebrafish and beyond
por: Kemmler, Cassie L., et al.
Publicado: (2023)

Evaluation of ROTARIX(®) Booster Dose Vaccination at 9 Months for Safety and Enhanced Anti-Rotavirus Immunity in Zambian Children: A Randomised Controlled Trial
por: Laban, Natasha Makabilo, et al.
Publicado: (2023)

Maternal and Infant Histo-Blood Group Antigen (HBGA) Profiles and Their Influence on Oral Rotavirus Vaccine (Rotarix(TM)) Immunogenicity among Infants in Zambia
por: Chauwa, Adriace, et al.
Publicado: (2023)

Collection of Recombinant Rotaviruses Expressing Fluorescent Reporter Proteins
por: Philip, Asha A., et al.
Publicado: (2019)

An ATP-responsive metabolic cassette comprised of inositol tris/tetrakisphosphate kinase 1 (ITPK1) and inositol pentakisphosphate 2-kinase (IPK1) buffers diphosphosphoinositol phosphate levels
por: Whitfield, Hayley, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_esvmvf3d3n05pf9sc2je7338n0